Vera Ramelli1, Sebastiano A G Lava2,3, Giacomo D Simonetti1,2, Mario G Bianchetti4,5, Gian Paolo Ramelli1, Gregorio P Milani6. 1. Pediatric Department of Southern Switzerland, 6500, Bellinzona, Switzerland. 2. University Children's Hospital Bern and University of Bern, Bern, Switzerland. 3. Pediatric Pharmacology and Pharmacogenetics, Hôpital Robert Debré, Paris, France. 4. Pediatric Department of Southern Switzerland, 6500, Bellinzona, Switzerland. mario.bianchetti@usi.ch. 5. Università della Svizzera Italiana, Lugano, Switzerland. mario.bianchetti@usi.ch. 6. Pediatric unit, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Abstract
The occurrence of blistering eruptions in childhood Henoch-Schönlein syndrome has been so far addressed exclusively in individual case reports. To describe epidemiology, clinical presentation, and therapeutic options in Henoch-Schönlein patients ≤18 years of age with blistering eruptions, we completed a systematic literature search. For the final analysis, we retained 39 reports. Ten children with blisters were found in 7 (1.5%) case series containing a total of 666 unselected pediatric Henoch-Schönlein cases. We also found 41 individually documented cases of Henoch-Schönlein syndrome with blistering eruptions. Blistering eruptions and purpura were distributed very similarly, blisters developed concomitantly with palpable purpura or with a latency of ≤14 days, and 80% of the cases remitted within 4 weeks with a similar course in children managed expectantly and in those managed with steroids. CONCLUSION: Blistering eruptions are rare in Henoch-Schönlein syndrome. They can be a source of diagnostic dilemma but do not have any prognostic value since they almost always spontaneously subside within 4 weeks. What is known: • Textbooks and reviews marginally refer to the occurrence of blistering eruptions in children with Henoch-Schönlein syndrome. What is new • Blistering eruptions occur in <2% of cases. • Blisters and purpura are distributed similarly, blisters develop concomitantly with purpura or with a latency of ≤14 days. • Almost all cases remit within 4 weeks with a similar course in children managed expectantly and in those managed with systemic steroids.
The occurrence of blistering eruptions in childhood Henoch-Schönlein syndrome has been so far addressed exclusively in individual case reports. To describe epidemiology, clinical presentation, and therapeutic options in Henoch-Schönlein patients ≤18 years of age with blistering eruptions, we completed a systematic literature search. For the final analysis, we retained 39 reports. Ten children with blisters were found in 7 (1.5%) case series containing a total of 666 unselected pediatric Henoch-Schönlein cases. We also found 41 individually documented cases of Henoch-Schönlein syndrome with blistering eruptions. Blistering eruptions and purpura were distributed very similarly, blisters developed concomitantly with palpable purpura or with a latency of ≤14 days, and 80% of the cases remitted within 4 weeks with a similar course in children managed expectantly and in those managed with steroids. CONCLUSION: Blistering eruptions are rare in Henoch-Schönlein syndrome. They can be a source of diagnostic dilemma but do not have any prognostic value since they almost always spontaneously subside within 4 weeks. What is known: • Textbooks and reviews marginally refer to the occurrence of blistering eruptions in children with Henoch-Schönlein syndrome. What is new • Blistering eruptions occur in <2% of cases. • Blisters and purpura are distributed similarly, blisters develop concomitantly with purpura or with a latency of ≤14 days. • Almost all cases remit within 4 weeks with a similar course in children managed expectantly and in those managed with systemic steroids.
Authors: M C Calviño; J Llorca; C García-Porrúa; J L Fernández-Iglesias; P Rodriguez-Ledo; M A González-Gay Journal: Medicine (Baltimore) Date: 2001-09 Impact factor: 1.889
Authors: Vera Ramelli; Pietro O Rinoldi; Mario G Bianchetti; Sebastiano A G Lava; Gian Paolo Ramelli; Gregorio P Milani Journal: Eur J Pediatr Date: 2019-10-19 Impact factor: 3.183
Authors: Sebastiano A G Lava; Gregorio P Milani; Emilio F Fossali; Giacomo D Simonetti; Carlo Agostoni; Mario G Bianchetti Journal: Clin Rev Allergy Immunol Date: 2017-12 Impact factor: 10.817
Authors: Giulia Rosti; Gregorio P Milani; Emanuela A Laicini; Emilio F Fossali; Mario G Bianchetti Journal: Ital J Pediatr Date: 2017-09-21 Impact factor: 2.638